Industry and Technology Intelligence

Tracking Where Innovation Is Happening and Where Industry Is Moving

Regulatory data can tell us more than which products received an authorization, or which companies faced enforcement action. Viewed across industries, technologies, companies, and markets, it can reveal where innovation is accelerating and how the regulated-product landscape is changing.

MDP Industry & Technology Intelligence connects regulatory activity with broader industry and technology developments to identify emerging fields, changing competitive landscapes, and trends that may influence future regulatory strategy.

Emerging Technology Intelligence

Artificial intelligence, digital health, robotics, advanced diagnostics, connected devices, novel manufacturing technologies, and other innovations are changing regulated products—and creating new regulatory questions.

MDP tracks regulatory activity involving emerging technologies to examine how they are reaching the market, where adoption is occurring, and how regulatory approaches evolve alongside innovation.

Industry & Therapeutic Area Intelligence

Innovation does not occur uniformly across regulated industries or clinical specialties. Regulatory activity can help identify areas experiencing increased development, changing technology, or shifting market activity.

MDP analyzes developments across medical devices, pharmaceuticals, biologics, diagnostics, and other regulated products, as well as therapeutic areas such as cardiovascular, orthopedics, radiology, neurology, and other specialties.

Company & Market Intelligence

Authorization, enforcement, recall, and other regulatory data can provide insight into individual companies and broader competitive activity.

MDP examines company activity over time to identify authorization patterns, product portfolios, regulatory events, technology development, and other indicators of industry activity.

Global Regulatory & Geographic Intelligence

The U.S. regulated-product market is global. Manufacturers, suppliers, developers, and regulatory authorities around the world influence the products reaching American patients and consumers.

MDP examines geographic patterns in regulatory activity to better understand where products and technologies originate, how international participation is changing, and where important industry developments are occurring.

From Regulatory Activity to Industry Intelligence

An individual regulatory event tells us something about a product or company. Viewed across thousands of events and over time, the same information can tell us something about an industry.

By connecting companies, technologies, therapeutic areas, product categories, countries, and regulatory activity, MDP seeks to identify emerging technologies, changing markets, and developments that regulated organizations should be watching.

As the MDP Regulatory Intelligence program grows, this page will connect to technology watches, company analyses, industry trends, geographic research, data visualizations, and other intelligence resources.

The regulatory activity shows us what is happening. Intelligence helps us understand where industry may be going next.

Regulatory Intelligence

MDP integrates six interconnected areas into a comprehensive intelligence model.

Market Authorization Intelligence

Track what is entering the market and how regulatory pathways are evolving.

Enforcement Intelligence

FDA enforcement activity provides an important window into emerging compliance risks.

Inspections and Compliance

Inspection outcomes can reveal how regulatory expectations are being applied in practice.

Policy & Regulatory Change

We follow these developments with an emphasis on what changed, who is affected, when it matters, and what regulated organizations should be considering next.

Industry and Technology

Regulatory data can also reveal where innovation is occurring.